Ferroptosis induction by engineered liposomes for enhanced tumor therapy

Ferroptosis has shown potential therapeutic effects in tumor therapy as an iron-dependent programmed cell death. The induction of ferroptosis is based on lipid peroxidation, the accumulation of iron and reactive oxygen species, and the depletion of glutathione. Nowadays, various nanoparticles are reported for ferroptosis-based therapy. Among them, engineered liposomes have received more attention due to their biocompatibility, low immunogenicity, and flexibility in chemical and structural modifications. The present review focuses on the mechanisms of ferroptosis and its induction by engineered liposomes to improve tumor therapy. It also highlights the fascinating outcome of liposome-mediated ferroptosis in overcoming the obstacles to cancer therapy, along with the limitations and possible future directions.